In case you missed it: Lithium acquisitions and extraordinary nickel processing for the third quarter | spcilvly

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small-cap stories that may have gone unnoticed.

Below is a summary of the 20 best-performing stocks, by percentage, that made announcements today.

ICYMI Leadership Board

WordPress Tables Plugin

Accelerate Resources (ASX:AX8) is acquiring the Karratha lithium projects, which include the Prinsep, Mt Sholl, Mt Sholl East and Roebourne South projects in the same belt it hosts Blue Minerals (ASX:AZS) ~$1.2 billion Andover discovery.

Panoramic Resources (ASX:PAN) says ore mined increased 5% and ore milled increased 25% during the September quarter at its Savannah nickel project in WA.

Ragusa Minerals (ASX:RAS) has begun RC drilling at its NT lithium project.

Mighty Kingdom (ASX:MKL) ) has appointed its current chief operating officer, Simon Rabbit, as interim chief executive.

AND Auteco Minerals (ASX:AUT) has closed its share purchase plan early for 3 million dollars.

More Small Cap Top Stories: Friday

Green Technology Metals (ASX:GT1) has begun drilling at its flagship 9Mt Seymour project, following initial exploration success at its Junior lithium project ~20km away.

Haranga Resources (ASX:HAR) has identified new anomalies of up to 17 ppm uranium over the Sanela prospect area ahead of planned drilling on its Saraya uranium permit in Senegal.

Summit Minerals (ASX:SUM) says ultrafine soil sampling has pointed to a new mineralized zone, called the MHC target, at its Stallion REE project in WA.

Anson Resources (ASX:ASN) has confirmed the location of its proposed processing plant at the Green River lithium project in Utah, USA.

Neurotechnology (ASX:NTI) has reported “highly significant” clinical improvements in its first clinical trial for pediatric patients with autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and patients with pediatric acute-onset neuropsychiatric syndrome (PANS) with its broad-spectrum cannabinoid drug therapy (NTI164 ).

AND Netlinkz (ASX:NET) has executed a convertible securities facility deal to raise up to A$10 million with US investor Obsidian Global GP to fund the company’s growth plans in Asia.

At Stockhead we tell it like it is. While Green Technology Metals, Haranga Resources, Summit Minerals, Anson Resources Neurotech International, Accelerate Resources and Netlinkz They are Stockhead advertisers, they did not sponsor this article.

You might be interested

Leave a Reply

Your email address will not be published. Required fields are marked *